<DOC>
	<DOC>NCT02561494</DOC>
	<brief_summary>Nefopam will be administered to the patients undergoing laparoscopic gastrectomy under the total intravenous anesthesia (TIVA). The investigators will evaluate whether the nefopam can decrease the total amount of remifentanil administered during the operation, which will reduce the acute opioid tolerance and following consumption of fentanyl during postoperative period.</brief_summary>
	<brief_title>Postoperative Analgesic Effect of Nefopam</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Nefopam</mesh_term>
	<criteria>Early or advanced gastric cancer Refusal Use of preoperative analgesic drugs Pregnancy Recurred gastric cancer Seizure Cardiac disease Monoamine oxidase inhibitor Urologic disease Previous intrabdominal surgery Body mass index &gt; 30 or &lt; 16</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>